“Osteo‐Organogenesis Niche” Hyaluronic Acid Engineered Materials Directing Re‐Osteo‐Organogenesis via Manipulating Macrophage CD44‐MAPK/ERK‐ETV1/5‐MRC1 Axis
Advanced Healthcare Materials · 2024
DOI: 10.1002/adhm.202403122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2024. Verfasst von Zongpu Han und 10 weiteren Autor:innen. Beteiligte Einrichtung: Hospital of Stomatology, Guanghua School of Stomatology, Sun Yat-sen University, and Guangdong Provincial Key Laboratory of Stomatology, Guangzhou, 5…. Hauptthemen laut MEDLINE: Hyaluronic Acid, Hyaluronan Receptors, Macrophages. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 67 Literaturangaben. Gefördert von: National Key R&D Program of China, Guangdong Basic and Applied Basic Research Foundation, National Natural Science Foundation of China.
Abstract (Originalsprache)
The strategy of re‐organogenesis provides an optimal framework for restoring complex organ structures and functions in adult damage. While the focus has often been on restoring organogenesis stem cells, there is limited investigations of reverting the environmental niche to support this approach. The guiding principle of “Nature selects the fittest to survive” drives the intricate dynamic changes in cellular events within the niche environment, especially through immune surveillance. The extracellular matrix (ECM) serves as the “self‐associated molecular patterns” of the niche, containing extensive data on cell‐niche reaction data and acting as the active tuner of immune surveillance. In this study, hyaluronic acid (HA) is identified as a unique component of the ECM in cranial osteo‐organogenesis. Mechanistically, HA activates the Cluster of Differentiation 44 (CD44)‐Mitogen‐Activated Protein Kinase (MAPK)/Extracellular Signal‐Regulated Kinase (ERK)‐Ets Variant 1/5 (ETV1/5)‐ Mannose Receptor C‐Type 1 (MRC1) axis in macrophages, establishing a distinct immune surveillance during osteo‐organogenesis. Furthermore, HA is utilized as a novel engineered material for an “Osteo‐organogenesis niche”, restoring immune surveillance and synergistically regulating stem cells to achieve re‐osteo‐organogenesis in cranial defects of rats. Taken together, the study unveils a previously unknown strategy for leveraging re‐organogenesis by utilizing “organogenesis niche” ECM engineered materials to manipulate immune surveillance, thereby comprehensively regulating stem cells and other tissue cells effectively for re‐organogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hospital of Stomatology, Guanghua School of Stomatology, Sun Yat-sen University, and Guangdong Provincial Key Laboratory of Stomatology, Guangzhou, 510055, China.
- Guangdong Research Center for Dental and Cranial Rehabilitation and Material Engineering, Guangzhou, 510055, China.
ORCID-Profile: Zetao Chen
Förderung
- National Key R&D Program of China
- Guangdong Basic and Applied Basic Research Foundation
- National Natural Science Foundation of China
- Science and Technology Program of Guangzhou, China
- National Key Research and Development Program of China
Zitieren
APA
Han, Z., Lin, Y., Guo, X., Xu, J., Gao, X., Yang, R., Zhao, Y., Gui, M., Zhang, L., Guo, Y., & Chen, Z. (2024). “Osteo‐Organogenesis Niche” Hyaluronic Acid Engineered Materials Directing Re‐Osteo‐Organogenesis via Manipulating Macrophage CD44‐MAPK/ERK‐ETV1/5‐MRC1 Axis. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202403122
Vancouver
Han Z, Lin Y, Guo X, Xu J, Gao X, Yang R, et al. “Osteo‐Organogenesis Niche” Hyaluronic Acid Engineered Materials Directing Re‐Osteo‐Organogenesis via Manipulating Macrophage CD44‐MAPK/ERK‐ETV1/5‐MRC1 Axis. Advanced Healthcare Materials. 2024. doi:10.1002/adhm.202403122
BibTeX
@article{Han2024,
author = {Han, Zongpu and Lin, Yixiong and Guo, Xinyu and Xu, Jieyun and Gao, Xiaomeng and Yang, Ruihan and Zhao, Yuan and Gui, Mixiao and Zhang, Linjun and Guo, Yuanlong and Chen, Zetao},
title = {“Osteo‐Organogenesis Niche” Hyaluronic Acid Engineered Materials Directing Re‐Osteo‐Organogenesis via Manipulating Macrophage CD44‐MAPK/ERK‐ETV1/5‐MRC1 Axis},
journal = {Advanced Healthcare Materials},
year = {2024},
doi = {10.1002/adhm.202403122}
}
EUVIMED